A new conotoxin isolated from Conus consors venom acting selectively on axons and motor nerve terminals through a Na+-dependent mechanism.
A novel conotoxin was isolated and characterized from the venom of the fish-hunting marine snail Conus consors. The peptide was identified by screening chromatography fractions of the crude venom that produced a marked contraction and extension of the caudal and dorsal fins in fish, and noticeable spontaneous contractions of isolated frog neuromuscular preparations. The peptide, named CcTX, had 30 amino acids and the following scaffold: X11CCX7CX2CXCX3C. At the frog neuromuscular junction, CcTx at nanomolar concentrations selectively increased nerve terminal excitability so that a single nerve stimulation triggered trains of repetitive or spontaneous synaptic potentials and action potentials. In contrast, CcTx had no noticeable effect on muscle excitability even at concentrations 100 x higher than those that affected motor nerve terminals, as revealed by direct muscle stimulation. In addition, CcTx increased miniature endplate potential (MEPP) frequency in a Ca2+-free medium supplemented with ethylene glycol-bis-(beta-aminoethyl ether)-N,N,N', N'-tetraacetic acid (EGTA). Blockade of voltage-dependent sodium channels with tetrodotoxin (TTX) either prevented or suppressed the increase of MEPP frequency induced by the toxin. CcTx also produced a TTX-sensitive depolarization of the nodal membrane in single myelinated axons giving rise, in some cases, to repetitive and/or spontaneous action potential discharges. In addition, CcTx increased the nodal volume of myelinated axons, as determined using confocal laser scanning microscopy. This increase was reversed by external hyperosmolar solutions and was prevented by pretreatment of axons with TTX. It is suggested that CcTx, by specifically activating neuronal voltage-gated sodium channels at the resting membrane potential, produced Na+ entry into nerve terminals and axons without directly affecting skeletal muscle fibres. CcTx belongs to a novel family of conotoxins that targets neuronal voltage-gated sodium channels.
Le Gall
F
F
Laboratoire de Neurobiologie Cellulaire et Moléculaire, UPR 9040, Centre National de la Recherche Scientifique, Gif sur Yvette, France.
Favreau
P
P
Benoit
E
E
Mattei
C
C
Bouet
F
F
Menou
J L
JL
Ménez
A
A
Letourneux
Y
Y
Molgó
J
J
D000200:Action Potentials / Q000187:drug effects; D000595:Amino Acid Sequence; D000818:Animals; D001369:Axons / Q000187:drug effects*; D001522:Behavior, Animal / Q000187:drug effects; D020916:Conotoxins / Q000737:chemistry / Q000302:isolation & purification* / Q000494:pharmacology*; D004594:Electrophysiology; D005399:Fishes / Q000502:physiology*; D015640:Ion Channel Gating / Q000187:drug effects; D013058:Mass Spectrometry; D008969:Molecular Sequence Data; D008978:Mollusk Venoms / Q000494:pharmacology*; D009046:Motor Neurons / Q000187:drug effects*; D009469:Neuromuscular Junction / Q000187:drug effects; D018377:Neurotransmitter Agents / Q000378:metabolism; D017729:Presynaptic Terminals / Q000187:drug effects*; D011901:Ranvier's Nodes / Q000187:drug effects; D012908:Snails / Q000502:physiology*; D012964:Sodium / Q000502:physiology*; D015222:Sodium Channels / Q000187:drug effects; D009435:Synaptic Transmission / Q000187:drug effects
D020916:Conotoxins; D008978:Mollusk Venoms; D018377:Neurotransmitter Agents; D015222:Sodium Channels; D012964:Sodium